Barbara Elena Stopschinski

Barbara Stopschinski practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Barbara Stopschinski's NPI, 1932668746, was assigned on March 19, 2019. Barbara Stopschinski graduated from Ruhr - University Bochum Faculty of Medicine in 2010. Barbara Stopschinski holds Texas license U3660.

Barbara Stopschinski's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Barbara Stopschinski's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Barbara Stopschinski is also affiliated with Baylor Scott & White Institute for Rehabilitation - Dallas. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Barbara Stopschinski to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Barbara Stopschinski practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Barbara Stopschinski's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Barbara Stopschinski is board certified in neurology by the American Board of Psychiatry and Neurology. Barbara Stopschinski is licensed in Texas.

CMS data shows 63 Medicare services from Barbara Stopschinski across 4 procedure codes in 2024, for 30 Medicare patients. Medicare paid $4,292 for them. Every service was in an office.

CMS counts 30 Medicare patients who saw Barbara Stopschinski in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Barbara Stopschinski's median patient age at 74, with 56% women.

In 2024, Barbara Stopschinski wrote 194 Medicare Part D claims for 42 patients. 99% of them were for generic drugs. CMS names the drug for 159 of them, across 6 drugs with 11 or more claims each, at $4,244 in total drug cost. In 2023, CMS named 58 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Barbara Stopschinski for performance year 2024, reported as part of a group. Barbara Stopschinski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Barbara Stopschinski as offering telehealth.

Dmand AI links 5 papers to Barbara Stopschinski, published from 2020 to 2025. 2025 was the busiest year, with 2. The most frequent topics are tau Proteins, Alzheimer Disease and Cognitive Dysfunction. Barbara Stopschinski has published most often in J Alzheimers Dis. Barbara Stopschinski's most frequent co-authors are Marc I. Diamond, MD, John Hart, MD and Brandon Blake Holmes, MD, PhD.

Barbara Stopschinski graduated from Ruhr - University Bochum Faculty of Medicine in 2010.

Barbara Stopschinski is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.